MOXIFLOXACIN HYDROC

Moxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4476 for delivery to the Navy Expeditionary Central Facility in Williamsburg, VA, with a required delivery window of 20 days. The contract specifies a total quantity of 24 bottles, each containing 30 tablets, with a unit price of $24.00 per bottle and no variance allowed in quantity. The product must comply with stringent packaging and labeling standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in commercial, durable containers that ensure safe transport via common carrier at the lowest cost. Shelf life is strictly limited to 36 months and non-extendable, with storage required at controlled room temperature and protection from high humidity. The item is regulated by the FDA, and bidders must provide full manufacturer details including NDC numbers, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. identified as potential suppliers. All packaging, marking, and shipment must adhere to DLA’s Master List of Technical and Quality Requirements, and hazardous material provisions apply as per FED-STD-313 and ASTM D3951 where applicable. Shipment must be made by the fastest traceable means, excluding parcel post, and must be palletized per RP001 requirements. The contract mandates delivery FOB destination, with inspection and acceptance occurring upon receipt at the delivery point, and all documentation must reflect compliance with DLA’s unit of issue and procurement standards.